NCT00391079 Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS Status COMPLETED Phase PHASE3
NCT00381264 Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00376506 A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia Status COMPLETED Phase PHASE2
NCT00370071 Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00364936 Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS) Status COMPLETED Phase PHASE1/PHASE2
NCT00355134 Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00344253 Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis Status COMPLETED Phase PHASE3
NCT00343590 Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study Status COMPLETED Phase NA
NCT00342381 Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation Status COMPLETED Phase PHASE2
NCT00342134 Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00340834 Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase Status COMPLETED Phase PHASE3
NCT00338637 Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit Status UNKNOWN Phase PHASE2
NCT00336557 Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy Status COMPLETED Phase N/A
NCT00334100 Treadmill Training in Chronic MS: Efficacy and Cost-effectiveness Status WITHDRAWN Phase NA
NCT00333138 Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00331747 Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate Status UNKNOWN Phase NA
NCT00324506 Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis Status COMPLETED Phase PHASE2